iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Update

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totaling 8,033 shares, an increase of 621.1% from the July 15th total of 1,114 shares. Approximately 2.2% of the shares of the company are short sold. Based on an average trading volume of 1,025 shares, the short-interest ratio is currently 7.8 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Price Performance

Shares of NYSEARCA BMED remained flat at $32.45 during mid-day trading on Thursday. The stock had a trading volume of 136 shares, compared to its average volume of 3,477. iShares Health Innovation Active ETF has a one year low of $25.52 and a one year high of $32.45. The firm has a market capitalization of $11.68 million, a P/E ratio of 24.91 and a beta of 0.73. The business’s 50-day simple moving average is $30.30 and its 200-day simple moving average is $29.62.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.